SP slides despite ann of contract early January. Macro remains bleakish and margins are being squeezed. Hard to maintain earnings, let alone increase them in these circumstances.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025